Opioid Use Treatment at Intervention Clinics Continues to Rise for Third Year
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 22, 2024 -- Opioid use disorder (OUD) treatment continued to increase in intervention clinics in the third year of implementation of the Massachusetts office-based addiction treatment (OBAT) model of nurse care management for OUD, according to a study published online Nov. 22 in JAMA Network Open.
Gwen T. Lapham, Ph.D., M.P.H., from the Kaiser Permanente Washington Health Research Institute in Seattle, and colleagues compared OUD medication treatment in intervention and usual care clinics over three years of implementation of the OBAT model of nurse care management for OUD in a preplanned secondary analysis of a cluster randomized implementation trial conducted in six health systems in five states. Eligible patients were aged 16 to 90 years visiting intervention or usual care clinics from three years before randomization to two years after.
Preintervention, 290,071 primary care patients were seen: 130,618 in intervention clinics and 159,453 in usual care clinics. The researchers found that intervention clinics provided 19.7 more patient-years of OUD treatment than usual care clinics per 10,000 primary care patients over three years postrandomization.
"Results suggest integration of a new model of OUD treatment into primary care takes time to overcome barriers and that implementation of the Massachusetts OBAT model leads to ongoing increases in OUD treatment among primary care patients in the third year of implementation," the authors write.
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-24 00:00
Read more
- What's the Link Between Memory Problems and Sexism?
- RSV Burden Remains High in Young Children in the United States
- Children With Primary Ciliary Dyskinesia Likely to Have Asthma
- FDA Approves Crenessity (crinecerfont) for the Treatment of Children and Adults with Classic Congenital Adrenal Hyperplasia
- Discontinuing Cholinesterase When Starting Memantine Not Tied to Institutionalization Care
- Hypovolemic Phlebotomy Beneficial Before Liver Resection
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions